| Home > Publications database > S4(13)-PV cell-penetrating peptide induces physical and morphological changes in membrane mimetic lipid systems and cell membranes: Implications for cell internalization |
| Journal Article | PHPPUBDB-20425 |
; ; ; ; ; ; ; ; ; ; ; ; ;
2012
Elsevier
Amsterdam
This record in other databases:
Please use a persistent id in citations: doi:10.1016/j.bbamem.2011.12.022
Abstract: The present work aims to gain insights into the role of peptide-lipid interactions in the mechanisms of cellular internalization and endosomal escape of the S4(13)-PV cell-penetrating peptide, which has been successfully used in our laboratory as a nucleic acid delivery system. A S4(13)-PV analogue, S4(13)-PVscr, displaying a scrambled amino acid sequence, deficient cell internalization and drug delivery inability, was used in this study for comparative purposes. Differential scanning calorimetry, fluorescence polarization and X-ray diffraction at small and wide angles techniques showed that both peptides interacted with anionic membranes composed of phosphatidylglycerol or a mixture of this lipid with phosphatidylethanolamine, increasing the lipid order, shifting the phase transition to higher temperatures and raising the correlation length between the bilayers. However, S4(13)-PVscr, in contrast to the wild-type peptide, did not promote lipid domain segregation and induced the formation of an inverted hexagonal lipid phase instead of a cubic phase in the lipid systems assayed. Electron microscopy showed that, as opposed to S4(13)-PVscr, the wild-type peptide induced the formation of a non-lamellar organization in membranes of HeLa cells. We concluded that lateral phase separation and destabilization of membrane lamellar structure without compromising membrane integrity are on the basis of the lipid-driven and receptor-independent mechanism of cell entry of S4(13)-PV peptide. Overall, our results can contribute to a better understanding of the role of peptide-lipid interactions in the mechanisms of cell-penetrating peptide membrane translocation, helping in the future design of more efficient cell-penetrating peptide-based drug delivery systems.
Keyword(s): Cell Membrane: chemistry (MeSH) ; Cell Membrane: metabolism (MeSH) ; Cell Membrane: ultrastructure (MeSH) ; Cell-Penetrating Peptides: chemistry (MeSH) ; Cell-Penetrating Peptides: pharmacokinetics (MeSH) ; Cell-Penetrating Peptides: pharmacology (MeSH) ; Drug Delivery Systems: methods (MeSH) ; HeLa Cells (MeSH) ; Humans (MeSH) ; Lipid Bilayers: chemistry (MeSH) ; Lipid Bilayers: metabolism (MeSH) ; Peptides: chemistry (MeSH) ; Peptides: pharmacokinetics (MeSH) ; Peptides: pharmacology (MeSH) ; Phosphatidylethanolamines: chemistry (MeSH) ; Phosphatidylethanolamines: metabolism (MeSH) ; Phosphatidylglycerols: chemistry (MeSH) ; Phosphatidylglycerols: metabolism (MeSH) ; Cell-Penetrating Peptides ; Lipid Bilayers ; Peptides ; Phosphatidylethanolamines ; Phosphatidylglycerols ; S4(13)-PV peptide ; phosphatidylethanolamine
|
The record appears in these collections: |